Protective effect of pharmacologic preconditioning with pioglitazone on random-pattern skin flap in rat is mediated by nitric oxide system

Journal of Surgical Research

Volumn 176, Issue 2, 2012, Pages 696-700

  Afraz, Sajjad ^a   Kamran, Ali ^a   Moazzami, Kasra ^a   Nezami, Behtash G ^a   Dehpour, Ahmad Reza ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

ischemic injury prevention; nitric oxide; pioglitazone; skin flap

Indexed keywords

ARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PIOGLITAZONE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; GRAFT DYSFUNCTION; MALE; MONOTHERAPY; NONHUMAN; PEDICLED SKIN FLAP; PILOT STUDY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RAT; SKIN FLAP SURVIVAL; SKIN TRANSPLANTATION; SYSTEMIC THERAPY;

ANIMALS; ARGININE; ENZYME INHIBITORS; GRAFT SURVIVAL; HYPOGLYCEMIC AGENTS; ISCHEMIC PRECONDITIONING; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; SKIN; SURGICAL FLAPS; THIAZOLIDINEDIONES;

EID: 84863986926     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2011.10.013     Document Type: Article

References (28)

1. C.L. Kerrigan Skin flap failure: Pathophysiology Plast Reconstr Surg 72 1983 766
2. C. Atalay, E.A. Kockaya, and B. Cetin Efficacy of topical nitroglycerin and transcutaneous electrical nerve stimulation on survival of random-pattern skin flaps in rats Scand J Plast Reconstr Surg Hand Surg 37 2003 10
3. S. Kiumehr, S. Demehri, and S. Rabbani Preconditioning of the rat random-pattern skin flap: Modulation by opioids Br J Plast Surg 58 2005 58
4. H. Matsumura, N. Yoshizawa, and N.B. Vedder Preconditioning of the distal portion of a rat random-pattern skin flap Br J Plast Surg 54 2001 58
5. C. Maldonado, W.K. Stadelmann, and S. Ramirez Preconditioning of latissimus dorsi muscle flaps with monophosphoryl lipid a Plast Reconstr Surg 111 2003 267
6. M. Hosnuter, O. Babuccu, and E. Kargi Dual preconditioning: Effects of pharmacological plus ischemic preconditioning on skin flap survival Ann Plast Surg 50 2003 398
7. B.G. Nezami, S. Rahimpour, and T. Gholipour Pharmacologic preconditioning of random-pattern skin flap in rats using local cyclosporine and FK-506: Interaction with nitric oxide system Ann Plast Surg 59 2007 435
8. R.E. Davis, J.H. Wachholz, and D. Jassir Comparison of topical anti-ischemic agents in the salvage of failing random-pattern skin flaps in rats Arch Facial Plast Surg 1 1999 27
9. T. Fujiwara, A. Okuno, and S. Yoshioka Suppression of hepatic gluconeogenesis in long-term Troglitazone treated diabetic KK and C57BL/KsJ-db/db mice Metabolism 44 1995 486
10. J. Plutzky The potential role of peroxisome proliferator-activated receptors on inflammation in type 2 diabetes mellitus and atherosclerosis Am J Cardiol 92 2003 34J
11. M. Stumvoll, and H.U. Haring Glitazones: Clinical effects and molecular mechanisms Ann Med 34 2002 217
12. R.A. Daynes, and D.C. Jones Emerging roles of PPARs in inflammation and immunity Nat Rev Immunol 2 2002 748
13. K. Ito, J. Shimada, and D. Kato Protective effects of pre-ischemic treatment with pioglitazone, a peroxisome proliferator-activated receptor-γ ligand, on lung ischemia-reperfusion injury in rats Eur J Cardiothorac Surg 25 2004 530
14. N.S. Wayman, Y. Hattori, and M.C. McDonald Ligands of the peroxisome proliferator-activated receptors (PPAR-γ and PPAR-α) reduce myocardial infarct size FASEB J 16 2002 1027
15. Y. Luo, W. Yin, and A.P. Signore Neuroprotection against focal ischemic brain injury by the peroxisome proliferator-activated receptor-γ agonist rosiglitazone J Neurochem 97 2006 435
16. A. Sivarajah, P.K. Chatterjee, and N.S. Patel Agonists of peroxisome-proliferator activated receptor-γ reduce renal ischemia/reperfusion injury Am J Nephrol 23 2003 267
17. M. Abdelrahman, A. Sivarajah, and C. Thiemermann Beneficial effects of PPAR-γ ligands in ischemia-reperfusion injury, inflammation and shock Cardiovasc Res 65 2005 772
18. A. Beheshtian, S. Demehri, and S. Kiumehr ATP-sensitive potassium channels mediate the anti-ischemic properties of ischemic and pharmacologic preconditioning in rat random-pattern skin flap Ann Plast Surg 57 2006 94
19. O. Gribbe, U.E. Samuelson, and N.P. Wiklund Effects of nitric oxide synthase inhibition on blood flow and survival in experimental skin flaps J Plast Reconstr Aesthet Surg 60 2007 287
20. T.L. Yue, J. Chen, and W. Bao In vivo myocardial protection from ischemia/reperfusion injury by the peroxisome proliferator-activated receptor-γ agonist rosiglitazone Circulation 104 2001 2588
21. A. Nakajima, K. Wada, and H. Miki Endogenous PPAR γ mediates anti-inflammatory activity in murine ischemia-reperfusion injury Gastroenterology 120 2001 460
22. H. Ichikawa, Y. Naito, and T. Takagi specific peroxisome proliferator-activated receptor-γ (PPAR-γ) ligand, pioglitazone, ameliorates gastric mucosal damage induced by ischemia and reperfusion in rats Redox Rep 7 2002 343
23. P.C. Goldsmith, T.A. Leslie, and N.A. Hayes Inhibitors of nitric oxide synthase in human skin J Invest Dermatol 106 1996 113
24. P.G. Cordeiro, D.P. Mastorakos, and Q.Y. Hu The protective effect of L-arginine on ischemia-reperfusion injury in rat skin flaps Plast Reconstr Surg 100 1997 1227
25. J.A. Polikandriotis, L.J. Mazzella, and H.L. Rupnow Peroxisome proliferator-activated receptor γ ligands stimulate endothelial nitric oxide production through distinct peroxisome proliferator-activated receptor γ-dependent mechanisms Arterioscler Thromb Vasc Biol 25 2005 1810
26. D. Li, K. Chen, and N. Sinha The effects of PPAR-γ ligand pioglitazone on platelet aggregation and arterial thrombus formation Cardiovasc Res 65 2005 907
27. A. von Knethen, and B. Brune PPAR-γ - An important regulator of monocyte/macrophage function Arch Immunol Ther Exp (Warsz) 51 2003 219
28. C. Jiang, A.T. Ting, and B. Seed PPAR-γ agonists inhibit production of monocyte inflammatory cytokines Nature 391 1998 82